Immunoglobulin G4−Related Sclerosing Disease Mimicking Invasive Tumor in the Nasal Cavity and Paranasal Sinuses

References

1. 1.↵
   1. Ishida M,
   2. Hotta M,
   3. Kushima R,
   4. et al

   . Multiple IgG4-related sclerosing lesions in the maxillary sinus, parotid gland and nasal septum. Pathol Int 2009; 59: 670–75

   CrossRefPubMed
2. 2.↵
   1. Ikeda R,
   2. Awataguchi T,
   3. Shoji F,
   4. et al

   . A case of paranasal sinus lesions in IgG4-related sclerosing disease. Otolaryngol Head Neck Surg 2010; 142: 458–59

   FREE Full Text
3. 3.↵
   1. Isaka Y,
   2. Yoshioka K,
   3. Nishio M,
   4. et al

   . A case of IgG4-related multifocal fibrosclerosis complicated by central diabetes insipidus. Endocr J 2008; 55: 723–28

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Boo H,
   2. Hogg JP

   . Nasal cavity neoplasms: a pictorial review. Curr Probl Diagn Radiol 2010; 39: 54–61

   CrossRefPubMed
5. 5.↵
   1. Yousem DM,
   2. Li C,
   3. Montone KT,
   4. et al

   . Primary malignant melanoma of the sinonasal cavity: MR imaging evaluation. Radiographics 1996; 16: 1101–10

   CrossRefPubMed
6. 6.↵
   1. Kim SS,
   2. Han MH,
   3. Kim JE,
   4. et al

   . Malignant melanoma of the sinonasal cavity: explanation of magnetic resonance signal intensities with histopathologic characteristics. Am J Otolaryngol 2000; 21: 366–78

   CrossRefPubMed
7. 7.↵
   1. Ou CH,
   2. Chen CC,
   3. Ling JC,
   4. et al

   . Nasal NK/T-cell lymphoma: computed tomography and magnetic resonance imaging findings. J Chin Med Assoc 2007; 70: 207–12

   CrossRefPubMed
8. 8.↵
   1. Nguyen DD,
   2. Loo BW Jr.,
   3. Tillman G,
   4. et al

   . Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol 2003; 82: 521–25

   CrossRefPubMedWeb of Science
9. 9.↵
   1. King AD,
   2. Lei KI,
   3. Richards PS,
   4. et al

   . Non-Hodgkin's lymphoma of the nasopharynx: CT and MR imaging. Clin Radiol 2003; 58: 621–25

   CrossRefPubMed
10. 10.↵
    1. Masaki Y,
    2. Dong L,
    3. Kurose N,
    4. et al

    . Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009; 68: 1310–15

    Abstract/FREE Full Text
11. 11.↵
    1. Shimatsu A,
    2. Oki Y,
    3. Fujisawa I,
    4. et al

    . Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 2009; 56: 1033–41. Epub 2009 Nov 19

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Zen Y,
    2. Fujii T,
    3. Harada K,
    4. et al

    . Th2 and regulatory immune reactions are increased in immunoglobulin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007; 45: 1538–46

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Nishino T,
    2. Toki F,
    3. Oyama H,
    4. et al

    . Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006; 45: 497–501

    CrossRefPubMed
14. 14.↵
    1. Cheuk W,
    2. Lee KC,
    3. Chong LY,
    4. et al

    . IgG4-related sclerosing disease: a potential new etiology of cutaneous pseudolymphoma. Am J Surg Pathol 2009; 33: 1713–19

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Sandanayake NS,
    2. Church NI,
    3. Chapman MH,
    4. et al

    . Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7: 1089–96

    CrossRefPubMed
16. 16.↵
    1. Khosroshahi A,
    2. Bloch DB,
    3. Deshpande V,
    4. et al

    . Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62: 1755–62

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Socolovsky M,
    2. Spaho N,
    3. Cueto DG,
    4. et al

    . Reactive lymphoid follicular hyperplasia mimicking a peripheral nerve tumor. Surg Neurol 2008; 70: 514–17

    CrossRefPubMed